日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells.

PARP14 介导的糖酵解增强雌激素受体阳性乳腺癌细胞对他莫昔芬的耐药性

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-02404-7
Mo Wenju, Zhang Fanrong, Wang Chen, Ding Xiaowen, Ren Lili
细胞生物学
乳腺癌
PARP1
发表日期：2025
文献求助 收藏

Oncoplastic Breast-Conserving Surgery for Upper Inner Quadrant Breast Cancer Using Pedicled Pectoralis Major Myofascial Flap

采用带蒂胸大肌肌筋膜瓣进行上内象限乳腺癌的肿瘤整形保乳手术

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S472263
Hu, Jie Jie; Qin, Chengdong; Liu, Siyuan; Zhu, Meizhen; Xia, Xianghou; Liang, Chenlu; Mao, Jiefei; Zhang, Fanrong; Yu, Yang
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis

lncRNA TDRKH-AS1 通过 miR-134-5p/CREB1 轴促进乳腺癌进展

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-023-04640-3
Ding, Yuqin; Huang, Yuting; Zhang, Fanrong; Gong, Lijie; Liang, Chenlu; Ding, Kaijing; He, Xiangming; Ding, Xiaowen; Chen, Yiding
肿瘤
肿瘤免疫
乳腺癌
CREB
lncRNA
EB1
发表日期：2023
文献求助 收藏

A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary

一种整合基因组和DNA甲基化谱分析的分子方法，用于鉴定原发灶不明的肺癌的组织来源。

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-022-03362-2
Chen, Kaiyan; Zhang, Fanrong; Yu, Xiaoqing; Huang, Zhiyu; Gong, Lei; Xu, Yanjun; Li, Hui; Yu, Sizhe; Fan, Yun
肺癌
肿瘤
表观遗传
肿瘤免疫
DNA甲基化
发表日期：2022
文献求助 收藏

Chinese Tea Alleviates CCl4-Induced Liver Injury through the NF-κBorNrf2Signaling Pathway in C57BL-6J Mice

中国茶通过 NF-κB 或 Nrf2 信号通路减轻 C57BL-6J 小鼠 CCl4 诱发的肝损伤

期刊:Nutrients
影响因子:4.8
doi:10.3390/nu14050972
Zhaoyu Wu, Lingli Sun, Ruohong Chen, Shuai Wen, Qiuhua Li, Xingfei Lai, Zhenbiao Zhang, Fanrong Cao, Shili Sun
代谢
信号转导
肝损伤
WB
NF-κB
发表日期：2022
文献求助 收藏

Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions

EGFR或HER2 20号外显子插入突变的非小细胞肺癌患者的免疫微环境特征及PD-1/PD-L1阻断疗效

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.13748
Chen, Kaiyan; Pan, Guoqiang; Cheng, Guoping; Zhang, Fanrong; Xu, Yanjun; Huang, Zhiyu; Fan, Yun
肺癌
肿瘤
HER2
肿瘤免疫
EGF
PD-L1
EGFR
细胞生物学
PD-1
免疫/内分泌
发表日期：2021
文献求助 收藏

The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience

新辅助化疗期间乳腺癌进展性疾病的治疗选择：单中心经验

期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.1080/15384047.2020.1756707
Zheng, Yurong; Ding, Xiaowen; Zou, Dehong; Zhang, Fanrong; Qin, Chengdong; Yang, Hongjian; Mo, Wenju; Ding, Yuqin; Yu, Yang
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases

肺癌-molGPA 指数可预测伴有同步或异时性脑转移的非小细胞肺癌患者的生存结局

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S255478
Chen, Kaiyan; Zhang, Fanrong; Fan, Yun; Cheng, Guoping
肺癌
肿瘤
肿瘤免疫
神经科学
细胞生物学
发表日期：2020
文献求助 收藏

Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma

TP53 DNA结合域的非破坏性突变是食管鳞状细胞癌的有利因素

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm.2020.02.142
Huang, Minran; Jin, Jiaoyue; Zhang, Fanrong; Wu, Yingxue; Xu, Chenyang; Ying, Lisha; Su, Dan
细胞生物学
肿瘤
P53
肿瘤免疫
发表日期：2020
文献求助 收藏

Complete mitochondrial genome of the Salangid icefish Neosalanx taihuensis (Actinopterygii: Osmeriformes: Salangidae)

太湖新冰鱼（Neosalanx taihuensis）（辐鳍鱼纲：鮟鱇目：冰鱼科）的完整线粒体基因组

期刊:Mitochondrial Dna Part B-Resources
影响因子:0.7
doi:10.1080/23802359.2018.1511840
Wang, Ying; Wen, Hanyu; Yao, Jiyuan; Sun, Kaixun; Wang, Wenbo; Liu, Hongyan; Yang, Dong; Zhang, Fanrong; Xiong, Fei
线粒体
发表日期：2018
文献求助 收藏